136 related articles for article (PubMed ID: 156038)
21. Tissue type plasminogen activator, but not urokinase, exerts transformation-enhancing activity.
De Petro G; Vartio T; Salonen EM; Vaheri A; Barlati S
Int J Cancer; 1984 May; 33(5):563-7. PubMed ID: 6539304
[TBL] [Abstract][Full Text] [Related]
22. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
23. [Thrombolytics and their use].
Alessi MC; Juhan-Vague I
Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
[TBL] [Abstract][Full Text] [Related]
24. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
Takada A; Urano T; Takada Y
Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes.
Dahl R; Venge P
Thromb Res; 1979; 14(4-5):599-608. PubMed ID: 483258
[No Abstract] [Full Text] [Related]
26. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
27. Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.
Sheth PM; Kahr WH; Haq MA; Veljkovic DK; Rivard GE; Hayward CP
Thromb Haemost; 2003 Aug; 90(2):293-8. PubMed ID: 12888877
[TBL] [Abstract][Full Text] [Related]
28. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
29. Receptor for plasmin on human carcinoma cells.
Burtin P; Fondaneche MC
J Natl Cancer Inst; 1988 Jul; 80(10):762-5. PubMed ID: 2838642
[TBL] [Abstract][Full Text] [Related]
30. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
Toki N; Takasugi S; Sumi H; Yamura T
Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
[TBL] [Abstract][Full Text] [Related]
31. The activation mechanism of human plasminogen.
Rickli EE
Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
[No Abstract] [Full Text] [Related]
32. Kinetic studies of three different molecular forms of urokinase for the activation of native human plasminogen.
Toki N; Takasugi S; Sumi H
Enzyme; 1981; 26(4):221-4. PubMed ID: 6788545
[TBL] [Abstract][Full Text] [Related]
33. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
Rosenthal SL; Zucker D; Davidson RL
J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
[TBL] [Abstract][Full Text] [Related]
34. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
35. Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
Thorsen S; Astrup T
Haemostasis; 1976; 5(5):295-305. PubMed ID: 14058
[TBL] [Abstract][Full Text] [Related]
36. Generation of macrophage migration inhibitory activity by plasminogen activators.
Roblin RO; Hammond ME; Bensky ND; Dvorak AM; Dvorak HF; Black PH
Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1570-4. PubMed ID: 193107
[TBL] [Abstract][Full Text] [Related]
37. The plasminogen content of commercial preparations and of normal donor plasma in relation to the plasmin content of the 1st international plasmin reference preparation.
Wolf P
Thromb Haemost; 1979 Aug; 42(2):582-95. PubMed ID: 159512
[TBL] [Abstract][Full Text] [Related]
38. The binding and processing of plasminogen by Balb/c 3T3 and SV3T3 cells.
Tobler J; Krieger M; Stroud RM
J Cell Physiol; 1981 Aug; 108(2):277-90. PubMed ID: 6267086
[TBL] [Abstract][Full Text] [Related]
39. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
Petersen LC; Brender J; Suenson E
Biochem J; 1985 Jan; 225(1):149-58. PubMed ID: 2579638
[TBL] [Abstract][Full Text] [Related]
40. The plasminogen activator and esterase activities of the two forms of urokinase.
Ong EB; Soberano ME; Johnson AJ; Dharmgrongartama ED
Thromb Res; 1981 Nov; 24(3):223-32. PubMed ID: 7038974
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
